Friday, July 29, 2016

Global Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic … – Business Wire (press release)

DUBLIN–(BUSINESS WIRE)–Research and Markets has actually announced the addition of the “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Medical Trials Review, H1, 2016” Medical trials to their offering.

The Medical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Medical Trials Review, H1, 2016” offers an summary of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Medical trials scenario. This report offers leading line data concerning the Medical trials about Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia). Report involves an summary of trial numbers and their standard enrollment in leading nations carried out across the globe.

The report provides coverage of ailment Medical trials by region, country (G7 & E7), phase, trial status, end factors standing and enroller type. Report additionally offers well-liked drugs with regard to in-improvement trials (based about variety of ongoing trials). Medical Trial Reports are generated utilizing our proprietary database – Pharma eTrack Medical trials database. Medical trials are collated from 80+ various Medical trial registries, conferences, journals, news and many more across the globe. This Medical trials database undergoes periodic updates by dynamic process.

The report raises the decision making capabilities and aids to make an efficient contrarily strategies to obtain competitive advantage.

Key Topics Covered:

  • The report offers a snapshot of the global Medical trials landscape
  • The report offers leading degree data related to the Medical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, enroller form and End point status
  • The report reviews leading business entailed and enlists Every one of trials (Trial title, Phase, and Status) pertaining to the company
  • The report offers Every one of the unaccomplished trials (Terminated, Suspended and Withdrawn) Along with requirement with regard to unaccomplishment
  • The report offers enrollment fads with regard to the record 5 years
  • The report offers latest news with regard to the record 3 months

Companies Mentioned:

  • Novartis AG
  • Sanofi
  • Bristol-Myers Squibb Company
  • Amgen Inc.
  • Pfizer Inc.
  • Jazz Pharmaceuticals Plc
  • Ariad Pharmaceuticals, Inc.
  • Celgene Corporation
  • Merck & Co., Inc.
  • Immunomedics, Inc.

For much more short article browse through http://ift.tt/2aCAEXq